Compounds > 1,7-phenanthroline
Page last updated: 2024-08-24

1,7-phenanthroline and Experimental Mammary Neoplasms

1,7-phenanthroline has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrams, MJ; Bradley, FC; Caruso, FS; Douple, EB; Giandomenico, CM; McElligott, MA; O'Hara, JA1
Breitman, ML; Dennis, JW; Feinmesser, R; Lala, PK; Waghorne, C; Yagel, S1

Other Studies

2 other study(ies) available for 1,7-phenanthroline and Experimental Mammary Neoplasms

ArticleYear
Combined modality treatment with ternary Cu(II) complexes and X rays.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3

    Topics: 2,2'-Dipyridyl; Adenocarcinoma; Animals; Cell Line; Cell Survival; Combined Modality Therapy; Cricetinae; Cricetulus; Dose-Response Relationship, Radiation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organometallic Compounds; Phenanthrolines; Radiation-Sensitizing Agents

1992
Evidence that beta 1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes.
    International journal of cancer, 1989, Oct-15, Volume: 44, Issue:4

    Topics: Alkaloids; Amnion; Animals; Basement Membrane; Cell Line; Female; Humans; Mammary Neoplasms, Experimental; Metalloendopeptidases; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Oligosaccharides; Phenanthrolines; Swainsonine; Tumor Cells, Cultured

1989